Tuesday, February 20, 2018 11:59:11 PM
It is good but I have seen better and combined with the lack of detail about the patients response leads me to conclude there may be more non-responders or low responders than many believe. If you have good data, you report it. They didn't, so one should reasonably be a bit skeptical until the company shares the data.
I am sure you recognize that the words in these press releases are very carefully chosen. They don't talk about filing a BLA and that is huge. They do talk about the mono trial and that tells me the data is not good enough for pursuing a BLA for combo (or the economics of it no longer make any sense) and can only be helpful for mono recruiting. Everyone will need to make their own judgment on this but I think it is very reasonable to read between the lines that there is some issue with the data.
CYDY was barely getting any money from PAulsen clients with each new round until this most recent one. That leads me to believe they must have given some pretty heavy hints that the data might be good in order to get the $10 million just before the critical data is released.
If that is true, the investors supplying the $10 million might well feel aggrieved and pursue legal action. Hardly seems like a baffling situation to me but each person has to draw their own conclusions and since we don't have all the needed info, people will reach different conclusions.
I agree with you on this. Those were horrible terms and to sell those shares and warrants just before the data release with the huge potential dilution coming from the conversion of the warrants just ahead. This management team is evidently not as confident in the future as many believe.
Here I just disagree straightforwardly with you and think the absence of BLA in the press release where key data is revealed is telling. The previous comments were made prior to the data. Since they did not mention it in the press release once the data was known seems like a very, very significant matter.
That plus there may be some shorting by some who hold warrants and plan to convert them. By shorting on the data release bounce, they lock in a profit on the warrant conversion.
I didn't accuse anyone, just urged that attitude since I knew my comments would not be welcome by many.
Recent CYDY News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:01:55 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM